Eikon Therapeutics bag $106m to fund eager acquisitions
Funding will be used to support the company’s platform based on Nobel Prize winning research.
News
Coherus allies with Mark Cuban to challenge AbbVie for Humira biosimilar
CMS mandates registry data for coverage of Alzheimer’s drugs
Novartis touts breast cancer win with “landmark” Kisqali results
AB Science announces Canadian patent for masitinib to treat ALS
EC approves Briumvi to treat relapsing forms of multiple sclerosis
Anavex Life Sciences receives US patent for ANAVEX 2-73 (blarcamesine)
Swiss company Lonza acquires Synaffix to boost ADC offering
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
